Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$47.98 - $54.4 $47,980 - $54,400
-1,000 Reduced 50.0%
1,000 $54,000
Q4 2023

Jan 29, 2024

BUY
$48.48 - $57.85 $96,960 - $115,700
2,000 New
2,000 $102,000
Q1 2021

Apr 12, 2021

BUY
$59.34 - $66.74 $35,604 - $40,044
600 New
600 $38,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Valeo Financial Advisors, LLC Portfolio

Follow Valeo Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.